Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Mucosal Immunity in Cystic Fibrosis.Journal of immunology (Baltimore, Md. : 1950) · 2021
   Review
2. The Distribution and Role of the CFTR Protein in the Intracellular Compartments.Membranes · 2021
   Review
3. Cost of precision medicine at a referral center for cystic fibrosis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2020
   Article
4. Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions.Multidisciplinary respiratory medicine · 2019
   Review
5. Assessing the Perceptions of Inspiratory Muscle Training in Children With Cystic Fibrosis and Their Multidisciplinary Team: Mixed-Methods Study.JMIR pediatrics and parenting · 2018
   Article
6. Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.JCI insight · 2018
   Article
7. Nasospheroids permit measurements of CFTR-dependent fluid transport.JCI insight · 2017
   Article
8. Can learning health systems help organisations deliver personalised care?BMC medicine · 2017
   Article
9. High-Definition Medicine.Cell · 2017
   Review
10. DNA Sequence Analysis in Clinical Medicine, Proceeding Cautiously.Frontiers in molecular biosciences · 2017
    Review
11. Towards precision medicine.Nature reviews. Genetics · 2016
    Review
12. Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.Drugs · 2016
    Review

Corrections and comments

• Commented on by
  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.2015
• Comment on
  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.2015

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as